Establishment of nomogram prediction model for patients with chronic obstructive pulmonary disease based on Lasso feature screening

基于Lasso特征筛选的慢性阻塞性肺疾病患者列线图预测模型的建立

阅读:1

Abstract

BACKGROUND AND OBJECTIVE: To establish a nomogram prediction model for patients with chronic obstructive pulmonary disease (COPD) based on Lasso feature screening using acoustic features and general clinical data, as well as a risk warning model for patients with acute exacerbation of COPD (AECOPD), and to investigate the performance and value of these two models. METHODS: A total of 240 male COPD patients, including 41 patients with acute exacerbation, and 82 healthy control male volunteers were enrolled as subjects from October 2022 to January 2024. Acoustic features and general clinical data were collected. Lasso regression was used to screen variables related to COPD and AECOPD diagnosis, and nomogram models were separately established and verified by the receiver operating characteristic (ROC) curve, calibration curve, and decision curve. RESULTS: Variables related to COPD diagnosis screened by Lasso regression included age, smoking history, a_Jitter, e_MFCC1, e_F2 frequency, i_H1-A3, i_F1 amplitude, o_F1 amplitude, and u_MFCC4, and the variables related to AECOPD included expectoration, mMRC grade, i_Jitter, i_F2 frequency, i_Alpha Ratio, and u_H1-H2. The ROC Curve showed that the Area Under the Curve (AUC) of the COPD nomogram model was 0.95, and the AUC of the AECOPD risk warning model was 0.83. The calibration curve indicated that nomogram models showed reasonable consistency, and the Mean Absolute Error (MAE) values were 0.026 and 0.028, respectively. The decision curve indicated that nomogram models showed good benefit, and the benefit thresholds were nearly full threshold, and 0.11-81 and 0.88-0.99, respectively. CONCLUSION: The nomogram models for COPD prediction and risk warning of AECOPD can be used as a clinical auxiliary diagnostic and early screening method, providing new insights into the intelligent auscultation of COPD.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。